tirzepatide retatrutide vs. Tirzepatide: The Next-Gen GLP-1 Showdown Weight Loss Blog – Maryland

Not only are there currently millions of people on these compounded drugs, all of whom would have to get new prescriptions to switch over to brand-name ones, but the market is ever-growing as these drugs gain new approved uses, like sleep apnea

However, some studies have reported that rosiglitazone and pioglitazone, both TZD drugs, could be associated with an increased risk of prostate and pancreatic cancer [107]

The SELECT trial demonstrated a 20% reduction in major adverse cardiovascular events (heart attack, stroke, cardiovascular death) in people with obesity and established cardiovascular disease

Despite its unlicensed status, retatrutide has begun appearing on the grey market, often sold as a 'research peptide' or 'research chemical'

New England J Med [Internet]

The best linker was used in dulaglutide and that linker prolonged the half-life but still did not impede the efficacy and potency of dulaglutide to raise cAMP in GLP-1R transfected cells (Glaesner et al